TB risk in autoimmune rheumatic disease patients
Part of Infections clinical trials.
This study is tracking how many people with autoimmune rheumatic diseases develop tuberculosis. By joining, you help doctors understand the risk better.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must have an autoimmune rheumatic disease (like lupus, rheumatoid arthritis, or others).
- At the start of the study, you must test negative for tuberculosis (TB) infection.
- You cannot have had TB in the past or been treated for TB.
- A chest X-ray must not show any signs of past TB.
- You must be willing to be part of the study for at least 12 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests health workers for tuberculosis (TB) infection to better understand who is at risk. It may help find ways to protect health workers from TB.
This study looks for people who have recently completed standard treatment for drug-sensitive TB. Researchers want to check if certain tests can predict long-term health outcomes after treatment.
This study aims to better understand how the immune system responds to tuberculosis (TB) and improve tools for diagnosing and managing the disease. It may help people with active TB, their close contacts, people with certain other lung diseases, or healthy individuals.
This study looks at immune system blood tests in adults being treated for active tuberculosis and/or latent tuberculosis infection. The goal is to see if these “immune biomarkers” can help guide or improve tuberculosis management.
This study follows patients being treated for tuberculosis with standard medications to see how well the treatment works and what side effects occur. Your medical records and check-ups help doctors understand which treatments are most effective.
This study screens people for tuberculosis (TB), a serious lung infection, using new testing methods. Researchers want to find TB cases early so people can get treatment before the disease becomes severe.
Hear when a new Autoimmune Rheumatic Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.